Latest by Barbara Jungwirth
Stroke risk among underrepresented populations; the realism of UNAIDS 90-90-90 goals; HIV persistence and inflammation amidst long-term suppression; HDL cholesterol as a predictor of immune recovery.
Case Management Improves Linkage to Care for People Living With HIV Post-Release From Prison or Jail, New Study Shows
People living with HIV who spent time in Connecticut correctional facilities and received transitional case management were more likely to be promptly linked to care after their release than those who did not receive such services.
How West Virginia is responding; a text-message based continuum-of-care intervention; PrEP and risk compensation; a link between inflammation, frailty, and cytomegalovirus infection.
Primary care + HIV care = improved health care engagement; the efficacy of different HIV testing and treatment interventions; abdominal fat and hypertension rates; the ethics of HIV phylogenetics.
The Fair Pricing Coalition is working with pharmaceutical companies to ensure fair prices for new HIV drugs on par with those of older medications.
Whether a local HIV outbreak in Tijuana, Mexico, may be related to police activity; PrEP and stigma in hookup apps; HIV, aging, and the immune system; cannabis as a systemic anti-inflammatory.
Presentations on women in research at this year's Conference on Retroviruses and Opportunistic Infections highlighted the lack of inclusion, offered ideas on how to remedy the situation, and showed how one woman moved from advocate to researcher.
Even in the modern treatment era, HIV-positive men who have sex with men are developing diabetes at an extremely high rate.
Long-term glucose disorders; anal vs. cervical HPV; PrEP adherence among U.S. veterans; economic incentives to spur HIV testing.
The effect of HIV treatment on HPV risk; bone mineral density declines in women vs. men; how hep C cure affects kidney function; when it comes to non-daily PrEP, location matters.